
Shares of Xpeng Rise 1.8% in Hong Kong Dual Primary Listing Debut
Xpeng’s shares rose 1.8% at the opening of trading to reach 168 Hong Kong dollars a piece, as the company carried out a dual primary listing on the Hong Kong Stock Exchange.
Showing 12 of 13113 posts
Xpeng’s shares rose 1.8% at the opening of trading to reach 168 Hong Kong dollars a piece, as the company carried out a dual primary listing on the Hong Kong Stock Exchange.
Geely Automobile Holdings is in talks with home appliance manufacturer Haier Group to sell the first model of its new electric vehicle (EV) brand at the latter's stores, according to Chinese media.
Salesforce announced on July 24 that Chinese e-commerce giant Alibaba is now the exclusive cloud services provider for the American Customer Relationship Management (CRM) service provider in Greater China.
Many users of QQ, a Chinese instant messaging software owned by Tencent, claimed on Sunday night that their accounts had been hacked. The app's official team responded on Monday.
Download the app, and you can win a flight!
On Dec. 16, the SEC announced that the accounting-fraudulent Luckin Coffee Inc. agreed to pay a $180 million penalty for previous charges concerning the company’s fabricated transactions.
On May 7, Budweiser Asia Pacific announced its unaudited Q1 2020 financial results. The company’s revenue in Q1 fell by 39%, while its revenue in the Chinese market fell by as much as 45.4%.
China's spending on research and development (R&D) hit a record high at 2.23% of its gross domestic product (GDP) in 2019, up by 0.09% from the previous year.
PDD jumped onto the bandwagon and partnered with Chinese integrated agricultural service giant Stanley Agriculture at the beginning of 2021.
Meituan-Dianping’s quarterly revenue reached 27.5 billion yuan ($3.9 billion), while the total transaction amount increased by 33.6% year-on-year to 194.6 billion yuan ($27.5 billion).
The research organ operated by leading Chinese e-commerce giant JD.com released a report on Friday offering insight into winter sports consumption in China.
Biocytogen, an emerging pharmaceutical technology company, announced today that it has completed a new round of funding worth tens of millions of dollars, jointly led by Lake Bleu Capital, China Pinnacle Equity Management, Octagon Capital and OrbiMed.